Inside your gut are trillions of microorganisms that are not your own cells, and scientists think they could hold the key to fighting disease.
A first step in learning more is to gather stool samples. That's the mission of The BioCollective, a Colorado-based company that gives people financial incentives to collect their stools for science. As part of a recently announced White House Initiative, The BioCollective will collect samples for research into how gut bacteria impact sickle cell, a disease afflicting 100,000 people in this country, most of them African-Americans. Martha Carlin, founder and CEO of The BioCollective in Centennial, spoke with Colorado Matters host Ryan Warner.
Listen to the interview here.